Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.

Antonella Fogliata, Marta Scorsetti, Piera Navarria, Maddalena Catalano, Alessandro Clivio, Luca Cozzi, Francesca Lobefalo, Giorgia Nicolini, Valentina Palumbo, Chiara Pellegrini, Giacomo Reggiori, Antonella Roggio, Eugenio Vanetti, Filippo Alongi, Sara Pentimalli, Pietro Mancosu

Journal: Acta oncologica (Stockholm, Sweden) 2013;52(3):545-52

PMID: 22671576

Abstract

BACKGROUND

To appraise the potential of volumetric modulated arc therapy (VMAT, RapidArc) and proton beams to simultaneously achieve target coverage and enhanced sparing of bone tissue in the treatment of soft-tissue sarcoma with adequate target coverage.

MATERIAL AND METHODS

Ten patients presenting with soft-tissue sarcoma of the leg were collected for the study. Dose was prescribed to 66.5 Gy in 25 fractions to the planning target volume (PTV) while significant maximum dose to the bone was constrained to 50 Gy. Plans were optimised according to the RapidArc technique with 6 MV photon beams or for intensity modulated protons. RapidArc photon plans were computed with: 1) AAA; 2) Acuros XB as dose to medium; and 3) Acuros XB as dose to water.

RESULTS

All plans acceptably met the criteria of target coverage (V95% >90-95%) and bone sparing (D(1 cm3) <50 Gy). Significantly higher PTV dose homogeneity was found for proton plans. Near-to-maximum dose to bone was similar for RapidArc and protons, while volume receiving medium/low dose levels was minimised with protons. Similar results were obtained for the remaining normal tissue. Dose distributions calculated with the dose to water option resulted ~5% higher than corresponding ones computed as dose to medium.

CONCLUSION

High plan quality was demonstrated for both VMAT and proton techniques when applied to soft-tissue sarcoma.

Address: Oncology Institute of Southern Switzerland, Medical Physics Unit, Bellinzona, Switzerland. [email protected]

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.